Showing results (491-500 of 539) with videos related to
Sort By:
Pageof 54
ACS Nano|April 10, 2012
Surface defects on plate-shaped silver nanoparticles contribute to its hazard potential in a fish gill cell line and zebrafish embryosSaji George, Sijie Lin, Zhaoxia Ji, et al.Journal of Cellular Physiology|July 8, 2010
Association of core-binding factor β with the malignant phenotype of prostate and ovarian cancer cellsJ Nathan Davis, Donna Rogers, Lisa Adams, et al.Proceedings of the National Academy of Sciences of the United States of America|January 27, 2025
Automating the practice of science: Opportunities, challenges, and implicationsSebastian Musslick, Laura K Bartlett, Suyog H Chandramouli, et al.Journal of Clinical Pharmacology|December 14, 2011
Multiple-dose safety, pharmacokinetics, and pharmacodynamics of the μ-opioid receptor inverse agonist GSK1521498Pradeep J Nathan, Mark A Bush, Wenli X Tao, et al.Molecular Cell|September 8, 2022
S1-END-seq reveals DNA secondary structures in human cellsGabriel Matos-Rodrigues, Niek van Wietmarschen, Wei Wu, et al.Plos One|November 19, 2013
Effects of the BDNF Val66Met polymorphism and met allele load on declarative memory related neural networksChris M Dodds, Richard N Henson, John Suckling, et al.BMC Psychiatry|April 4, 2014
Distribution of tract deficits in schizophreniaIan Ellison-Wright, Pradeep J Nathan, Edward T Bullmore, et al.Alzheimer'S Research & Therapy|April 22, 2021
Safety, pharmacokinetics and exploratory pro-cognitive effects of HTL0018318, a selective M1 receptor agonist, in healthy younger adult and elderly subjects: a multiple ascending dose studyCharlotte Bakker, Tim Tasker, Jan Liptrot, et al.Molecular Cancer Research : MCR|June 4, 2011
The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ductal adenocarcinoma metastasisViviane Palhares Muniz, J Matthew Barnes, Seema Paliwal, et al.British Journal of Clinical Pharmacology|April 23, 2021
Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M1 -acetylcholine receptor agonist: A randomized cross-over trialCharlotte Bakker, Samantha Prins, Jan Liptrot, et al.Pageof 54